Advancements in the Treatment of Malignant PEComas with mTOR InhibitorsDecember 12, 2024Rare Diseases
National Organization for Rare Disorders: Strengthening Rare Cancer AdvocacyDecember 12, 2024Rare Diseases
2024 Rare Diseases Report: Hematology and OncologyDecember 12, 2024Rare DiseasesLung CancerCNS/Brain CancerT Cell Lymphomas
Current Management and Future Directions in the Treatment of Gallbladder CancerDecember 12, 2024Rare Diseases
Improving Prognosis in Hepatoblastoma: Evolving Risk Stratification and Treatment StrategiesDecember 12, 2024Rare Diseases
Hematology NewsScurvy: A Diagnosis Still Relevant TodayNovember 8, 2024GastroenterologyRare DiseasesAnemia
Oncology PracticeDermatomyositis Cancer Screening Guidelines Get Real-World ValidationOctober 3, 2024Rare DiseasesPreventive Care
Oncology PracticeFDA Approves First Engineered Cell Therapy for a Solid TumorAugust 2, 2024Sarcoma & GISTPatient & Survivor CareCNS/Brain CancerNeuro-oncologyNonmelanoma Skin CancerMetastatic Breast CancerPractice Management
Oncology PracticeDermatofibrosarcoma Protuberans More Common In Black Patients, Analysis FindsJuly 2, 2024Rare DiseasesNonmelanoma Skin CancerDiversity in MedicineSarcoma & GIST
Hematology NewsVEXAS Syndrome: Study Highlights Cutaneous SymptomsJune 20, 2024Rare DiseasesMixed Topics
Oncology PracticeUnleashing Our Immune Response to Quash CancerFebruary 21, 2024Immuno-oncologyGene TherapyMixed TopicsPatient & Survivor CarePediatricsAggressive LymphomasALL
Hematology NewsUnexplained collapse unveils rare blood disorderNovember 17, 2023AnemiaCOVID-19 UpdatesRare Diseases
Hematology NewsFDA approves first tx for rare, deadly clotting disorderNovember 13, 2023Bleeding DisordersThrombosisRare Diseases
